Skip to main content

Patients

About Barostim
Clinical Results
Reimbursement
Resources

Healthcare Professionals
Clinical Results
Reimbursement
Resources

For Patients
Contact

Press Release

CVRx^® BAROSTIM Therapy Receives CMS Approval for Transitional Pass-Through Payment Status

Effective December 2, 2020

Read press release

Follow Us

Patients

Home
Getting Barostim
Patient Stories
FAQ

Healthcare Professionals

Healthcare Professionals
Clinical Results
Reimbursement

About Us

Investors
Overview
Our Team
Newsroom
Careers
Contact Us

CVRx, Barostim, BAT, Barostim NEO, Barostim NEO2, BATwire, Outsmart the heart, and Barohub are all trademarks of CVRx, Inc. © 2026 CVRx, Inc. All rights reserved. All other trademarks are property of their respective owners.

Intellectual Property
Terms of Use
Privacy Policy
Cookie Policy
Applicant Policy
Accessibility Statement
AdvaMed Code of Ethics
MedTech Europe Code of Ethics
Important Safety & Regulatory Information
Instructions For Use

You are about to leave the CVRx website.

The website you are about to access may be governed by different regional policies, regulations or advertising codes. Please be sure to read the privacy notice, cookie notice and terms of use of the websites that you visit.

CVRx is not responsible for the accuracy or compliance with laws of information on any third party websites.

Do you wish to proceed?

Continue